Results 151 to 160 of about 232,812 (303)

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

VIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

Innovations and Inequalities: The Challenge of Access in Multiple Myeloma Management in Brazil. [PDF]

Hematol Transfus Cell Ther
Ribeiro GN, Crusoé EQ, Maiolino A, Hungria VTM.   +3 more
europepmc   +1 more source

Extramedullary Plasmacytoma of Base of Tongue: A Systematic Review

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective Identifying extramedullary plasmacytoma originating from the base‐of‐tongue, in order to evaluate its prevalence, characteristics, management, and treatment within the broader spectrum of head and neck extramedullary plasmacytoma.
Ori Cohen Michael, Ameen Biadsee, Firas Kassem, Matan Katz, Osnat Jarchowsky‐Dolberg, Benny Nageris, Tomer Boldes   +6 more
wiley   +1 more source

Adapting a mental health program for people with multiple myeloma and smouldering myeloma: a consumer-informed feasibility study. [PDF]

Support Care Cancer
Tuckey N, Iasiello M, Cantley M, van Agteren J, Beer H, Fassnacht DB, Ramsey I, Edney LC, Moussa RS, Grundy L, Ryan M, Ali K, Wardill HR.   +12 more
europepmc   +1 more source

Extramedullary myeloma progressed to plasmablastic myeloma

Clinical Hematology International
Ke Xu, Charalampia Kyriakou
openaire   +2 more sources

Risk of Cancer With Hormone Replacement Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue, Zachary Nash, Vikram Talaulikar, Shibani Nicum   +3 more
wiley   +1 more source

SEI1 complex silences p53 to drive myeloma progression. [PDF]

iScience
Chen R, Liu R, Fang Z, Yang D, Li Z, Li Y, Li Y, Liu S, Liu Q, Chao Y, Wang C, Liu H.   +11 more
europepmc   +1 more source

Targeting the mTOR and TRAIL Pathways in Multiple Myeloma. Resumen de tesis

, 2012
Extracto de tesis.[ES] Aunque hay varios estudios que destacan la activación de la vía PI3K/Akt en mieloma, hay menos información sobre el estado y el papel de la vía mTOR.
Chen, Xi
core  

Medication Related Osteonecrosis of the Jaw: Knowledge, Attitudes and Practice Patterns Among Australian Dental Practitioners

Australian Dental Journal, EarlyView.
ABSTRACT Background Medication related osteonecrosis of the jaw (MRONJ) is a debilitating condition associated with antiresorptive and antiangiogenic therapies. As the use of these medications continues to increase, dental practitioners play a critical role in prevention and management of at‐risk patients. This survey evaluated the awareness, knowledge
Ying Shi Chang, Christopher Friel, Gary Low, Albert Yaacoub, Stephen Clive Cox   +4 more
wiley   +1 more source

Routine Laboratory-Based Machine Learning for Discriminating Multiple Myeloma from Clinical Mimickers: Development and Internal Validation of a Diagnostic Prediction Model. [PDF]

Diagnostics (Basel)
Erdoğdu B, Gül D, Aylı BI, Karadeniz M, Yıldırım M, Cömert M.   +5 more
europepmc   +1 more source